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Results: Datasets from 10 patients were obtained for a total 
of 705 CBCT scans – the first 3 patients were excluded from 
the study due to changes in methodology partly through 
treatment. The mean 3D vector of residual setup error post 
first correction (6DOF) was 0.7 ± 0.4 mm (mean ± SD) and the 
maximum 3D vector was 2.2mm. The mean 3D vector of 
residual setup error post second correction (4DOF) was 0.2 ± 
0.1mm and the maximum 3D vector was 0.8mm. The mean 
3D vector of intra-fraction motion was 0.4 ± 0.2mm and the 
maximum 3D vector was 1.3mm. 
 
Conclusion: Incorporating a second correction pre-treatment 
significantly reduced the residual inter-fraction setup error 
from 0.7 ± 0.4 mm to 0.2 ± 0.1mm. The intra-fraction motion 
for this cohort of patients was twice as large as the residual 
inter-fraction setup error. Efforts are currently underway to 
reduce this intra-fraction motion by focusing on 
improvements to the immobilization system. 
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Purpose or Objective: Recently we introduced an improved 
hybrid treatment planning technique for breast with 
simultaneous irradiation of axillary and supraclavicular lymph 
nodes (level I-IV). This technique combines tangential open 
fields with VMAT (RapidArc®, Varian Medical Systems) and 
results in a highly conformal coverage of the lymph node 
region, with a steep dose fall-off towards esophagus and 
thyroid. The purpose of this study is to evaluate the validity 
of this conformal planning technique, with the required setup 
and image guidance. 
 
Material and Methods: Ten patients were included, of which 
8 were treated in Free Breathing and 2 were treated in Deep 
Inspiration Breathhold. Fractionation was 16 x 267 cGy for 
both elective breast and lymph node regions. PTV-margin of 
level I-IV lymph nodes is 5 mm to the medial direction and 
8mm for all other directions (image 1). Daily online setup was 
performed on bony anatomy with 2 orthogonal kV-images and 
subsequent verified with medio-lateral MV field imaging. At 
the level of the PTVnodes setup deviation up to 3mm was 
allowed in lateral direction, in all other directions and for 
the humeral head 5mm was allowed. At the first 3 fractions 
and weekly a CBCT was acquired for verification of the PTV-
coverage of the lymph nodes. All CBCT’s were used offline 
for analysis of the reproducibility of level I-II nodes, level III-
IV nodes, humeral head and bony anatomy. All 160 fractions 
were used for evaluation of the efficiency of the setup and 
imaging procedure. 
 
 
 
Results: A t-test showed a significant relation between the 
position of the humeral head and all the nodes in cranio-
caudal direction (p=<0.001) and for level III-IV also in lateral 
direction (p=0.01). Repositioning was required in 31 fractions 
(19%). This was reduced to 19 fractions (12%) by excluding 1 
patient with positioning problems. Based on the CBCT’s, we 
found that only in 2% of all cases, an off-set of the humeral 
head less than 8mm lead to a deviation of the nodal PTV of 
more than 5mm. Analysis of the CBCT’s also showed that the 
remaining average setup error for level I-II nodes and level 
III-IV nodes was less than 2mm in all directions with SD of 
max 1.6mm in AP direction (Table 1). 
 
 
 
Conclusion: The positioning of the lymph nodes level I-IV can 
be well addressed by the position of the surrounding bony 
anatomy and the humeral head. For the adequate treatment 
of both the lymph node regions and the breast, two 
orthogonal kV-images and MV field imaging are sufficient.  
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Purpose or Objective: Late genitourinary (GU) and 
gastrointestinal (GI) toxicities are the main dose limiting 
factors prostate radiotherapy plans. However, no predictive 
models, and consequently, no consensus guidelines have been 
reported for GU toxicity. One possible explanation is that the 
plan dose-volume histogram (DVH) is not representative of 
the accumulated bladder dose throughout the treatment 
given variability in bladder filling status, motion and set-up 
uncertainties. Modern image guidance techniques, in 
particular the use of cone beam computed tomography 
(CBCT), facilitates reconstruction of the accumulated dose. 
The aim of the study was to compare planned with 
accumulated dose and volume data for the bladder with the 
latter assessed from daily CBCT imaging and deformable 
image registration (DIR). 
 
Material and Methods: Eight subjects presenting with RTOG 
GU Grade 2+toxicity were selected from a cohort of 287 
patients treated for prostate cancer in 2006-2013. Prescribed 
dose was 81Gy in 45 fractions. The 8 subjects were each 
matched to 3 patients without GU toxicity by the following 
criteria: pretreatment GU symptoms (IPSS score), age ± 5y, 
risk group (low, intermediate, high), whole pelvis vs. 
prostate, and use of neoadjuvant ADT. Treatment required 
adherence to a full bladder and empty rectum protocol. Daily 
CBCT was used for patient realignment and to assess bladder 
and rectal filling status. Dose from planning CT was rigidly 
registered to CBCT using recorded daily shifts followed by 
bladder contour propagation from plan CT to the first day 
CBCT and then to the remaining CBCTs using an intensity-
based deformable image registration (DIR) algorithm. Bladder 
contours were corrected manually and the accumulated D10 
and D20 (defined as the highest dose received by a volume up 
to 10 and 20 cm3 of the bladder, respectively) were 
compared to corresponding values from the planned DVH. All 
registrations and DVHs computations were done using MIM 
Maestro 6.4.4 (Mim Software Inc. Cleveland, OH, US). 
 
Results: In the analyzed patients, the bladder volumes in the 
daily CBCTs were found to vary between 62% and 256% of 
that from the planning CT, with a mean difference in volume 
ranging from 63% to 20%. Differences in the compared DVH 
were also observed where D10 was ±2.7%, and D20 ±11.2% of 
the corresponding planned metrics. 
